BeStock  
Stocks › Biotechnology › HALO

Halozyme Therapeutics HALO

US equityMarket cap rank #1380Biotechnology
$91.35 −$1.69 (-1.82%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $91.35 0.00%
Open$93.64
Prev close$93.04
Day range$90.79 – $93.64
Volume1.50M
Market cap$10.41B
P/E (TTM)22.8
Dividend yield–

Analyst view

ConsensusBuy
Analysts5
Average target$125.60+37.5% vs. price
  • Buy 80%
  • Hold 20%
Low $109.00Now $91.35Avg $125.60High $149.00

Recent rating changes

The last 20 actions on file set price targets from $93.00 to $149.00, averaging $117.00.

DateFirmRatingTarget
20 Nov 2026 H.C. Wainwright BUY $130.00
17 Nov 2026 Morgan Stanley HOLD $109.00
10 Nov 2026 Morgan Stanley HOLD $109.00
6 Nov 2026 Citizens JMP BUY $149.00
6 Nov 2026 H.C. Wainwright BUY $130.00
16 Oct 2026 H.C. Wainwright BUY $130.00
15 Oct 2026 H.C. Wainwright BUY $130.00
13 Oct 2026 TD Cowen BUY $130.00
12 Oct 2026 H.C. Wainwright BUY $130.00
7 Oct 2026 Leerink Partners BUY $110.00
7 Oct 2026 H.C. Wainwright BUY $115.00
3 Sep 2026 H.C. Wainwright BUY $115.00
2 Sep 2026 H.C. Wainwright BUY $115.00
18 Aug 2026 H.C. Wainwright BUY $115.00
17 Aug 2026 H.C. Wainwright BUY $115.00
7 Aug 2026 TD Cowen BUY $105.00
7 Aug 2026 Wells Fargo HOLD $95.00
7 Aug 2026 Citizens JMP BUY $93.00
7 Aug 2026 Morgan Stanley BUY $105.00
7 Aug 2026 Leerink Partners BUY $110.00

Discussion

No comments yet — be the first to weigh in on HALO.

Sign in to join the discussion.

Scroll to Top